000 01161 a2200301 4500
005 20250515080330.0
264 0 _c20070924
008 200709s 0 0 eng d
022 _a0950-9232
024 7 _a10.1038/sj.onc.1210599
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aYang, X-J
245 0 0 _aHATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention.
_h[electronic resource]
260 _bOncogene
_cAug 2007
300 _a5310-8 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAcetylation
650 0 4 _aEnzyme Inhibitors
_xtherapeutic use
650 0 4 _aHistone Acetyltransferases
_xantagonists & inhibitors
650 0 4 _aHistone Deacetylase Inhibitors
650 0 4 _aHistone Deacetylases
_xchemistry
650 0 4 _aHumans
650 0 4 _aLysine
_xmetabolism
650 0 4 _aProtein Processing, Post-Translational
700 1 _aSeto, E
773 0 _tOncogene
_gvol. 26
_gno. 37
_gp. 5310-8
856 4 0 _uhttps://doi.org/10.1038/sj.onc.1210599
_zAvailable from publisher's website
999 _c17225683
_d17225683